Literature DB >> 6580554

Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.

R Willemze, W E Fibbe, F E Zwaan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6580554

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  3 in total

1.  Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia.

Authors:  U Jehn; N Göldel; R Rienmüller; W Wilmanns
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 2.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

Review 3.  Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment.

Authors:  W Hiddemann; T Büchner
Journal:  Blut       Date:  1990-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.